AUSTIN, Texas, June 21, 2018 (GLOBE NEWSWIRE) — SmallCapVoice, Inc. and Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, announced today that the Company is featured in a new audio interview at SmallCapVoice, Inc.
S. Parikh Mars, CEO of Progressive Care Inc., called in to SmallCapVoice, Inc. to answer shareholder questions, discuss the impact of recent news about CVS entering the prescription delivery market, provide an update on several fronts and more. Recently, RXMD announced further growth year-over-year in both revenue and number of prescriptions filled for May 2018. The May sales figures come on the heels of some significant company announcements including the launch of a nationwide opioid marketing campaign, the purchase and installation of a new TCGRx pouch packaging system and the initial steps in developing a proprietary tele-pharmacy software.
Progressive Care Inc. (), through PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management (MTM), prescription medications to long term care facilities, and health practice risk management.
SmallCapVoice, Inc. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients‘ financial news releases. SmallCapVoice also offers individual investors all the tools they need to make informed decisions about the stocks in which they are interested. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice and its services, please visit
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company‘s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations:
Tory Patterson, CMW Media
Public Relations Consultant
Investor Relations:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Copyright 2023 © PharmCo, LLC Subsidiary of progressive care inc. (OTCQB: RXMD)
